Journal
Autophagy
Publication Date
3-1-2023
Volume
19
Issue
3
First Page
1000
Last Page
1025
Document Type
Open Access Publication
DOI
10.1080/15548627.2022.2103961
Rights and Permissions
Chouhan S, Sawant M, Weimholt C, Luo J, Sprung RW, Terrado M, Mueller DM, Earp HS, Mahajan NP. TNK2/ACK1-mediated phosphorylation of ATP5F1A (ATP synthase F1 subunit alpha) selectively augments survival of prostate cancer while engendering mitochondrial vulnerability. Autophagy. 2023 Mar;19(3):1000-1025. doi: 10.1080/15548627.2022.2103961. © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
Recommended Citation
Chouhan, Surbhi; Sawant, Mithila; Weimholt, Cody; Luo, Jingqin; Sprung, Robert W; Terrado, Mailyn; Mueller, David M; Earp, H Shelton; and Mahajan, Nupam P., "TNK2/ACK1-mediated phosphorylation of ATP5F1A (ATP synthase F1 subunit alpha) selectively augments survival of prostate cancer while engendering mitochondrial vulnerability." Autophagy. 19, 3. 1000 - 1025. (2023).
https://digitalcommons.wustl.edu/oa_4/3167
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
